Panacea Biotec's lenders approve one-time settlement of outstanding dues

10 Apr 2019 Evaluate

Panacea Biotec’s  lenders has approved a one-time settlement plan to clear outstanding dues. All consortium lenders have approved the bilateral one-time settlement (OTS) at 65% of their outstanding debts.

The settlement has been done to resolve the current debt position of the company.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities. It is one of the largest vaccine producers and biotechnology companies in India.

Panacea Biotec Share Price

346.70 -4.95 (-1.41%)
17-Dec-2025 11:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.30
Dr. Reddys Lab 1276.00
Cipla 1493.60
Zydus Lifesciences 917.00
Lupin 2116.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×